Approval for changes to the labeling to support compatibility of the devices with MR environments up to 3.0 Tesla.  The device, as modified, will be marketed under the trade name AMPLATZER Septal Occluder (ASO) Device with the following indications for use: The AMPLATZER Septal Occluder (ASO) Device is indicated for the occlusion of atrial septal defects (ASD) in secundum position.  The ASO device is also indicated in patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.  Patients indicated for ASD closure have echocardiographic evidence of ostium secundum atrial septal defect and clinical evidence of right ventricular volume overload (i. e., 1.5:1 degree of left to right shunt or RV enlargement).